Blood pressure control and its associated factors in patients with hypertension and type 2 diabetes
More details
Hide details
College of Pharmacy, Al Ain University, Abu Dhabi, UAE
Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, JORDAN
Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, JORDAN
Department of Pharmacy, Jordanian Royal Medical Services, Amman, JORDAN
Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, UAE
Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, JORDAN
Online publication date: 2023-03-05
Publication date: 2023-05-01
Electron J Gen Med 2023;20(3):em477
In this retrospective study, the medical records of hypertensive patients with type 2 diabetes attending two major hospitals were reviewed to find the factors associated with poor blood pressure control in patients who have diabetes as a comorbid disease with hypertension. Binary regression analysis was conducted to find the factors independently associated with BP control. A total of 522 participants were included in the study. Most of the participants had uncontrolled hypertension (63.4%) and uncontrolled type 2 diabetes (51.3%). Regression results revealed that having retinopathy (OR=1.468 (95% CI: 1.020-2.113), p<0.05), and not receiving dipeptidyl-peptidase 4 (DPP4) inhibitors were independently associated with uncontrolled BP (OR=0.633 (95%CI 0.423-0.946), p<0.05). Therefore, greater efforts should be exerted to improve BP control in hypertensive patients with type 2 diabetes, particularly in those suffering from retinopathy.
Sabuncu T, Sonmez A, Eren MA, et al. Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish nationwide survey of glycemic and other metabolic parameters of patients with diabetes mellitus (TEMD hypertension study). Prim Care Diabetes. 2021;15(2):332-9. https://doi.org/10.1016/j.pcd.... PMid:33277201.
Perreault L, Pan Q, Aroda VR, et al. Exploring residual risk for diabetes and microvascular disease in the diabetes prevention program outcomes study (DPPOS). Diabet Med. 2017;34(12):1747-55. https://doi.org/10.1111/DME.13... PMid:28833481 PMCid:PMC5687994.
Mills H, Acquah R, Tang N, et al. Type 2 diabetes mellitus (T2DM) and carbohydrate metabolism in relation to T2DM from endocrinology, neurophysiology, molecular biology, and biochemistry perspectives. Evid Based Complement Alternat Med. 2022;2022:1708769. https://doi.org/10.1155/2022/1... PMid:35983003 PMCid:PMC9381199.
Aroda VR, Knowler WC, Crandall JP, et al. Metformin for diabetes prevention: Insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia. 2017;60(9):1601-11. https://doi.org/10.1007/S00125... PMid:28770322 PMCid:PMC5709233.
Bae JH, Han K Do, Ko SH, et al. Diabetes fact sheet in Korea 2021. Diabetes Metab J. 2022;46(3):417-26. https://doi.org/10.4093/dmj.20... PMid:35656565 PMCid:PMC9171160.
Akalu Y, Yeshaw Y, Tesema GA, et al. Suboptimal blood pressure control and its associated factors among people living with diabetes mellitus in sub-Saharan Africa: A systematic review and meta-analysis. Syst Rev. 2022; 11(1):1-14. https://doi.org/10.1186/s13643... PMid:36243876 PMCid:PMC9569048.
Dedefo MG, Gemechu DB, Fekadu G, Tekle Dibessa T. Blood pressure control among hypertensive diabetic patients on follow-up at chronic clinic of Nekemte Referral Hospital in West Ethiopia. Int J Hypertens. 2020;2020:7526257. https://doi.org/10.1155/2020/7... PMid:32637172 PMCid:PMC7322590.
Akalu Y, Belsti Y. Hypertension and its associated factors among type 2 diabetes mellitus patients at Debre Tabor General Hospital, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2020;13:1621-31. https://doi.org/10.2147/DMSO.S... PMid:32494180 PMCid:PMC7231788.
Rabizadeh S, Gholami B, Mahmoudzadeh Kani S, et al. Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates? J Clin Hypertens (Greenwich). 2021;23(9):1776-85. https://doi.org/10.1111/JCH.14... PMid:34418281 PMCid:PMC8678846.
Abdelbagi O, Musa IR, Musa SM, ALtigani SA, Adam I. Prevalence and associated factors of hypertension among adults with diabetes mellitus in northern Sudan: A cross-sectional study. BMC Cardiovasc Disord. 2021;21:168. https://doi.org/10.1186/S12872... PMid:33838664 PMCid:PMC8037914.
Flack JM, Calhoun D, Schiffrin EL. The new ACC/AHA hypertension guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults. Am J Hypertens. 2018;31(2):133-5. https://doi.org/10.1093/AJH/HP... PMid:29228096.
American Diabetes Association. Glycemic targets: Standards of medical care in diabetes–2020. Diabetes Care. 2020;43(Supplement_1):S66-76. https://doi.org/10.2337/DC20-S... PMid:31862749.
Ogah OS, Rayner BL. Recent advances in hypertension in sub-Saharan Africa. Heart. 2013;99(19):1390-7. https://doi.org/10.1136/HEARTJ... PMid:23708775.
Mogre V, Abedandi R, Salifu ZS. Prevalence of obesity and systemic hypertension among diabetes mellitus patients attending an out-patient diabetes clinic in a Ghanaian Teaching Hospital. Diabetes Metab Syndr. 2014;8(2):67-71. https://doi.org/10.1016/j.dsx.... PMid:24907168.
Tatsumi Y, Ohkubo T. Hypertension with diabetes mellitus: Significance from an epidemiological perspective for Japanese. Hypertens Res. 2017;40(9):795-806. https://doi.org/10.1038/hr.201... PMid:28701739.
Tesfaye B, Alebel A, Gebrie A, et al. Diabetes mellitus and its association with hypertension in Ethiopia: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2019;156:107838. https://doi.org/10.1016/j.diab... PMid:31520712.
Al-Jbour B, Kamel AA, Barhoom H. Knowledge about hypertension and antihypertensive medication compliance in a Jordanian community sample. J Educ Pract. 2013;4(24):81-7.
Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NRC. Cardiovascular outcomes in framingham participants with diabetes. Hypertension. 2011;57(5):891-7. https://doi.org/10.1161/HYPERT... PMid:21403089 PMCid:PMC3785072.
Unadike BC, Eregie A, Ohwovoriole AE. Prevalence of hypertension amongst persons with diabetes mellitus in Benin City, Nigeria. Niger J Clin Pract. 2011;14(3):300. https://doi.org/10.4103/1119-3... PMid:22037073.
Salanitro AH, Roumie CL. Blood pressure management in patients with diabetes. Clin Diabetes. 2010;28(3):107-14. https://doi.org/10.2337/DIACLI....
Almalki ZS, Albassam AA, Alhejji NS, Alotaibi BS, Al-Oqayli LA, Ahmed NJ. Prevalence, risk factors, and management of uncontrolled hypertension among patients with diabetes: A hospital-based cross-sectional study. Prim Care Diabetes. 2020;14(6):610-5. https://doi.org/10.1016/j.pcd.... PMid:32115377.
Sreedevi A, Krishnapillai V, Menon VB, et al. Uncontrolled blood pressure and associated factors among persons with diabetes: A community based study from Kerala, India. Front Public Heal. 2022;9:778235. https://doi.org/10.3389/fpubh.... PMid:35186868 PMCid:PMC8850699.
Sorato MM, Davari M, Kebriaeezadeh A, Sarrafzadegan N, Shibru T. Blood pressure and blood glucose control and associated factors among adults with hypertension at three public hospitals in Southern Ethiopia. High Blood Press Cardiovasc Prev. 2022;29(3):287-304. https://doi.org/10.1007/S40292... PMid:35403966.
Meelab S, Bunupuradah I, Suttiruang J, et al. Prevalence and associated factors of uncontrolled blood pressure among hypertensive patients in the rural communities in the central areas in Thailand: A cross-sectional study. PLoS One. 2019;14(2):e0212572. https://doi.org/10.1371/JOURNA... PMid:30779818 PMCid:PMC6380583.
de Pablos-Velasco P, Gonzalez-Albarran O, Estopiñan V, Khanbhai A. Blood pressure, antihypertensive treatment and factors associated with good blood pressure control in hypertensive diabetics: The Tarmidas study. J Hum Hypertens. 2007;21(8):664-72. https://doi.org/10.1038/sj.jhh... PMid:17460709.
Gebremichael GB, Berhe KK, Zemichael TM. Uncontrolled hypertension and associated factors among adult hypertensive patients in Ayder comprehensive specialized hospital, Tigray, Ethiopia, 2018. BMC Cardiovasc Disord. 2019;19(1):1-10. https://doi.org/10.1186/s12872... PMid:31117945 PMCid:PMC6532230.
Lemessa F, Lamessa M. Uncontrolled hypertension and associated factors among hypertensive adults in Bale Zone public hospitals, Ethiopia. J Hypertens Manag. 2021;7:057. https://doi.org/10.23937/2474-....
Tesfaye B, Haile D, Lake B, Belachew T, Tesfaye T, Abera H. Uncontrolled hypertension and associated factors among adult hypertensive patients on follow-up at Jimma University Teaching and Specialized Hospital: Cross-sectional study. Res Reports Clin Cardiol. 2017;8:21-9. https://doi.org/10.2147/RRCC.S....
Sarfo FS, Mobula LM, Burnham G, et al. Factors associated with uncontrolled blood pressure among Ghanaians: Evidence from a multicenter hospital-based study. PLoS One. 2018;13(3): e0193494. https://doi.org/10.1371/JOURNA... PMid:29554106 PMCid:PMC5858765.
de Paula Araújo T, Borges LGS, Barroso WKS, et al. Factors associated with uncontrolled blood pressure in hypertensive Brazilians. J Clin Hypertens. 2022;24(7):814-24. https://doi.org/10.1111/JCH.14... PMid:35770852 PMCid:PMC9278566.
Cordero A, Bertomeu-Martínez V, Mazón P, et al. Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease. Rev Esp Cardiol. 2011;64(7):587-93. https://doi.org/10.1016/J.RECE... PMid:21640460.
Fekadu G, Adamu A, Gebre M, et al. Magnitude and determinants of uncontrolled blood pressure among adult hypertensive patients on follow-up at Nekemte Referral Hospital, Western Ethiopia. Integr Blood Press Control. 2020;13:49. https://doi.org/10.2147/IBPC.S... PMid:32368134 PMCid:PMC7183335.
Dharmapatni NWK, Sriyuktasuth A, Pongthavornkamol K. Rate of uncontrolled blood pressure and its associated factors in patients with predialysis chronic kidney disease in Bali, Indonesia. J Heal Res. 2020;34(6):535-45. https://doi.org/10.1108/JHR-09....
Rahman M, Dixit A, Donley V, et al. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis. 1999;33(3):498-506. https://doi.org/10.1016/S0272-... PMid:10070914.
Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6(1):92. https://doi.org/10.4239/wjd.v6... PMid:25685281 PMCid:PMC4317321.
Chase HP, Garg SK, Jackson WE, et al. Blood pressure and retinopathy in type I diabetes. Ophthalmology. 1990;97(2): 155-9. https://doi.org/10.1016/S0161-... PMid:2326002.
Fujisawa T, Ikegami H, Yamato E, et al. Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in type 2 diabetes mellitus. Diabet Med. 1999;16(6):522-6. https://doi.org/10.1046/J.1464... PMid:10391402.
Gillow JT, Gibson JM, Dodson PM. Hypertension and diabetic retinopathy–what’s the story? Br J Ophthalmol. 1999;83(9):1083-7. https://doi.org/10.1136/BJO.83... PMid:10460781 PMCid:PMC1723193.
Liu L, Quang ND, Banu R, et al. Hypertension, blood pressure control and diabetic retinopathy in a large population-based study. PLoS One. 2020;15(3):e0229665. https://doi.org/10.1371/JOURNA... PMid:32134944 PMCid:PMC7058315.
Arora G. Diabetic retinopathy: Know how uncontrolled diabetes can affect your vision and what you can do to prevent it. Available at: https://doctor.ndtv.com/diabet... (Accessed: 14 September 2022).
Cosenso-Martin LN, Giollo-Junior LT, Vilela-Martin JF. DPP-4 inhibitor reduces central blood pressure in a diabetic and hypertensive patient: A case report. Medicine (Baltimore). 2015;94(27):e1068. https://doi.org/10.1097/MD.000... PMid:26166078 PMCid:PMC4504643.
Van Poppel PCM, Netea MG, Smits P, Tack CJ. Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes. Diabetes Care. 2011;34(9):2072-7. https://doi.org/10.2337/DC10-2... PMid:21788633 PMCid:PMC3161271.
Ogawa S, Ishiki M, Nako K, et al. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetes. Tohoku J Exp Med. 2011;223(2):133-5. https://doi.org/10.1620/TJEM.2... PMid:21304217.
Zhang X, Zhao Q. Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis. J Hypertens. 2016;34(2):167-75. https://doi.org/10.1097/HJH.00... PMid:26682782.
Wilson JR, Garner EM, Mashayekhi M, et al. DPP4 (dipeptidyl peptidase-4) inhibition increases catecholamines without increasing blood pressure during sustained ACE (angiotensin-converting enzyme) inhibitor treatment. Hypertension. 2022;79(4):827-35. https://doi.org/10.1161/HYPERT... PMid:35045722.
Jackson EK, Dubinion JH, Mi Z. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Clin Exp Pharmacol Physiol. 2008;35(1):29-34. https://doi.org/10.1111/J.1440... PMid:18047624.